MAPT and Alzheimer disease: To our knowledge, this is the first study to implicate TFF3 as a marker for neurodegeneration across the AD spectrum, and furthermore to show that this is independent of t-tau and p-tau: while there are few data on which to suggest mechanisms, one intriguing possibility is that this effect might in some way be mediated by alterations in gamma-secretase processing.